Suchergebnisse - "Smit, Egbert F"

PubPharm (570)

1

Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01) : primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial

enthalten in: The Lancet. Oncology | 2024

von Smit, E. | Felip, E. | Uprety, D. | +17

2

BRAFV600E-mutant metastatic NSCLC : disease overview and treatment landscape

enthalten in: NPJ precision oncology | 2024

von Planchard, D. | Sanborn, R. | Negrao, M. | +2

3

Combining Genomic Biomarkers to Guide Immunotherapy in Non-Small Cell Lung Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von van de Haar, J. | Mankor, J. | Hummelink, K. | +6

4

Osimertinib Plasma Trough Concentration in Relation to Brain Metastases Development in Patients With Advanced EGFR-Mutated NSCLC

enthalten in: JTO clinical and research reports | 2024

von Gulikers, J. | Veerman, G. | Jebbink, M. | +12

5

Cemiplimab in locally advanced or metastatic cutaneous squamous cell carcinoma : prospective real-world data from the DRUG Access Protocol

enthalten in: The Lancet regional health. Europe | 2024

von Verkerk, K. | Geurts, B. | Zeverijn, L. | +14

6

A phase 2 trial combining afatinib with cetuximab in patients with EGFR exon 20 insertion-positive non-small cell lung cancer

enthalten in: Cancer | 2024

von van Veggel, B. | van der Wekken, A. | Paats, M. | +8

7

Tertiary lymphoid structure-related immune infiltrates in NSCLC tumor lesions correlate with low tumor-reactivity of TIL products

enthalten in: bioRxiv.org | 2024

von Castenmiller, S. | Kanagasabesan, N. | Guislain, A. | +9

8

A Dysfunctional T-cell Gene Signature for Predicting Nonresponse to PD-1 Blockade in Non-small Cell Lung Cancer That Is Suitable for Routine Clinical Diagnostics

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Hummelink, K. | Tissier, R. | Bosch, L. | +10

9

A plain language summary of the PHAROS study : the combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer

enthalten in: Future oncology (London, England) | 2024

von Riely, G. | Smit, E. | Ahn, M. | +22

10

Clinical Relevance of High Plasma Trough Levels of the Kinase Inhibitors Crizotinib, Alectinib, Osimertinib, Dabrafenib, and Trametinib in NSCLC Patients

enthalten in: Therapeutic drug monitoring | 2024

von Lin, L. | Barkman, H. | Smit, E. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[57]